Overview

The 18th Annual Interventional Cardiology Fellows Course is a three-day meeting for the advanced trainee in interventional cardiology to be exposed to the facets of complex coronary and endovascular interventions. The international faculty includes many acknowledged pioneers and innovators in the field. The format consists of didactic lectures and angiographic reviews of challenging cases—with ample opportunities for interactions with the world-renowned faculty.

The course agenda offers in-depth coverage of the major issues in today’s practice of interventional vascular medicine, including performance of complex angioplasty, evidence-based medicine recommendations for appropriate drug-eluting stent use, and interventions in patients with acute coronary syndrome. There will be special emphases on adjunct pharmacological agents, imaging modalities, endovascular intervention, and structural heart disease.

Learning Objectives

After completion of this course, participants should be able to:

Compare and contrast the current practices and controversies surrounding advanced coronary and vascular interventions and drugs
Appraise the newest technologies and drugs
Apply evidence-based medicine from clinical trials during revascularization decisions

Target Audience

This course is designed for interventional cardiology fellows in ACGME accredited fellowship programs, interventional cardiology fellows in non-ACGME fellowship programs, fellows in cardiovascular disease fellowship programs, and established interventional cardiologists.

Activity Evaluation

Evaluation by questionnaire will address content, presentation, possible bias, and future educational needs.

Disclosure Statement

It is the policy of the Cardiovascular Research Foundation to ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational programs. Commercial support from industry does not influence educational content, faculty selection, and/or faculty presentations, and, therefore, does not compromise the scientific integrity of the educational activity.

Discussion of off-label product usage and/or off-label product use is made at the sole discretion of the faculty. Off-label product discussion and/or off-label product use is not endorsed by the Cardiovascular Research Foundation or the conference directors for this activity.

Faculty participating in continuing medical education activities sponsored by the Cardiovascular Research Foundation are required to disclose to the program audience any real or apparent conflict of interest related to the content of their presentation(s). Faculty not complying with this policy are not permitted to participate in this activity.